184 related articles for article (PubMed ID: 20101393)
1. Depressive and anxiety symptomatology in ecstasy users: the relative contribution of genes, trauma, life stress and drug use.
Scott RM; Hides L; Allen JS; Burke R; Lubman DI
Psychopharmacology (Berl); 2010 Mar; 209(1):25-36. PubMed ID: 20101393
[TBL] [Abstract][Full Text] [Related]
2. Coping style and ecstasy use motives as predictors of current mood symptoms in ecstasy users.
Scott RM; Hides L; Allen JS; Lubman DI
Addict Behav; 2013 Oct; 38(10):2465-72. PubMed ID: 23770644
[TBL] [Abstract][Full Text] [Related]
3. Ecstasy (MDMA) and high prevalence psychiatric symptomatology: somatic anxiety symptoms are associated with polydrug, not ecstasy, use.
Bedi G; Van Dam NT; Redman J
J Psychopharmacol; 2010 Feb; 24(2):233-40. PubMed ID: 18832429
[TBL] [Abstract][Full Text] [Related]
4. Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users: the longitudinal perspective.
Thomasius R; Zapletalova P; Petersen K; Buchert R; Andresen B; Wartberg L; Nebeling B; Schmoldt A
J Psychopharmacol; 2006 Mar; 20(2):211-25. PubMed ID: 16510479
[TBL] [Abstract][Full Text] [Related]
5. Is emotional intelligence impaired in ecstasy-polydrug users?
Craig L; Fisk JE; Montgomery C; Murphy PN; Wareing M
J Psychopharmacol; 2010 Feb; 24(2):221-31. PubMed ID: 18801831
[TBL] [Abstract][Full Text] [Related]
6. Anxiety, depression, and behavioral symptoms of executive dysfunction in ecstasy users: contributions of polydrug use.
Medina KL; Shear PK
Drug Alcohol Depend; 2007 Mar; 87(2-3):303-11. PubMed ID: 17074449
[TBL] [Abstract][Full Text] [Related]
7. Subacute effects of ecstasy on mood: an exploration of associated risk factors.
Scott RM; Hides L; Allen JS; Lubman DI
J Psychopharmacol; 2013 Jan; 27(1):53-61. PubMed ID: 23095244
[TBL] [Abstract][Full Text] [Related]
8. Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users.
Thomasius R; Petersen K; Buchert R; Andresen B; Zapletalova P; Wartberg L; Nebeling B; Schmoldt A
Psychopharmacology (Berl); 2003 Apr; 167(1):85-96. PubMed ID: 12632248
[TBL] [Abstract][Full Text] [Related]
9. An investigation of factors associated with depressive symptoms among a sample of regular ecstasy consumers.
Matthews AJ; Bruno R
Neuropsychobiology; 2010; 61(4):215-22. PubMed ID: 20389132
[TBL] [Abstract][Full Text] [Related]
10. Depressive mood ratings are reduced by MDMA in female polydrug ecstasy users homozygous for the l-allele of the serotonin transporter.
Kuypers KPC; de la Torre R; Farre M; Xicota L; de Sousa Fernandes Perna EB; Theunissen EL; Ramaekers JG
Sci Rep; 2018 Jan; 8(1):1061. PubMed ID: 29348651
[TBL] [Abstract][Full Text] [Related]
11. Long-term neuropsychological effects of ecstasy in middle-aged ecstasy/polydrug users.
Schilt T; Koeter MW; Smal JP; Gouwetor MN; van den Brink W; Schmand B
Psychopharmacology (Berl); 2010 Jan; 207(4):583-91. PubMed ID: 19823808
[TBL] [Abstract][Full Text] [Related]
12. Mood disorders and serotonin transporter density in ecstasy users--the influence of long-term abstention, dose, and gender.
de Win MM; Reneman L; Reitsma JB; den Heeten GJ; Booij J; van den Brink W
Psychopharmacology (Berl); 2004 May; 173(3-4):376-82. PubMed ID: 14726997
[TBL] [Abstract][Full Text] [Related]
13. 5-HTTLPR polymorphism, mood disorders and MDMA use in a 3-year follow-up study.
Martín-Santos R; Torrens M; Poudevida S; Langohr K; Cuyás E; Pacifici R; Farré M; Pichini S; de la Torre R
Addict Biol; 2010 Jan; 15(1):15-22. PubMed ID: 19878141
[TBL] [Abstract][Full Text] [Related]
14. Recreational use of "ecstasy" (MDMA) is associated with elevated impulsivity.
Morgan MJ
Neuropsychopharmacology; 1998 Oct; 19(4):252-64. PubMed ID: 9718589
[TBL] [Abstract][Full Text] [Related]
15. Recreational ecstasy/MDMA and other drug users from the UK and Italy: psychiatric symptoms and psychobiological problems.
Parrott AC; Milani RM; Parmar R; Turner JD
Psychopharmacology (Berl); 2001 Dec; 159(1):77-82. PubMed ID: 11797073
[TBL] [Abstract][Full Text] [Related]
16. The harmful health effects of recreational ecstasy: a systematic review of observational evidence.
Rogers G; Elston J; Garside R; Roome C; Taylor R; Younger P; Zawada A; Somerville M
Health Technol Assess; 2009 Jan; 13(6):iii-iv, ix-xii, 1-315. PubMed ID: 19195429
[TBL] [Abstract][Full Text] [Related]
17. The sub-acute effects of recreational ecstasy (MDMA) use: a controlled study in humans.
Huxster JK; Pirona A; Morgan MJ
J Psychopharmacol; 2006 Mar; 20(2):281-90. PubMed ID: 16510486
[TBL] [Abstract][Full Text] [Related]
18. An investigation into the sub-acute effects of ecstasy on aggressive interpretative bias and aggressive mood - are there gender differences?
Hoshi R; Pratt H; Mehta S; Bond AJ; Curran HV
J Psychopharmacol; 2006 Mar; 20(2):291-301. PubMed ID: 16510487
[TBL] [Abstract][Full Text] [Related]
19. Hug drug or thug drug? Ecstasy use and aggressive behavior.
Reid LW; Elifson KW; Sterk CE
Violence Vict; 2007; 22(1):104-19. PubMed ID: 17390566
[TBL] [Abstract][Full Text] [Related]
20. Decreased cerebral cortical serotonin transporter binding in ecstasy users: a positron emission tomography/[(11)C]DASB and structural brain imaging study.
Kish SJ; Lerch J; Furukawa Y; Tong J; McCluskey T; Wilkins D; Houle S; Meyer J; Mundo E; Wilson AA; Rusjan PM; Saint-Cyr JA; Guttman M; Collins DL; Shapiro C; Warsh JJ; Boileau I
Brain; 2010 Jun; 133(Pt 6):1779-97. PubMed ID: 20483717
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
